Clover Leaf Capital Corp.
CLOE · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -4.88 | -1.07 | 1.88 | 1.69 |
| FCF Yield | -0.45% | -0.43% | -0.30% | -1.04% |
| EV / EBITDA | -221.55 | -167,528.63 | -185.65 | 613,644.62 |
| Quality | ||||
| ROIC | -3.82% | -3.92% | -2.63% | -3.42% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.84 | 0.80 | 0.80 | 2.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -7.98% | -39.49% | 70.56% | -88.32% |
| Safety | ||||
| Net Debt / EBITDA | -14.62 | -10,152.29 | -10.02 | 30,122.25 |
| Interest Coverage | -50.60 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |